Vasculitis

Updated Consensus Statement for IL-6 Pathway Inhibition in Inflammatory Diseases

Publish Date September 7, 2022

A multidisciplinary group reviewed the current literature to create an updated consensus statement regarding the use of IL-6 inhibition for inflammatory conditions.

Rituximab Associated With Better Outcomes in ANCA-Associated Vasculitis

Publish Date August 23, 2022

Researchers examined outcomes and adverse events associated with rituximab therapy in older adult patients with ANCA-associated vasculitis.

Case Study: ANCA-negative Small Vessel Vasculitis

Publish Date July 8, 2022

Case study of a 70-year-old man who presents with vague signs of a rheumatic disease.

Vasculitis Risk With mRNA COVID-19 Vaccine vs Influenza Vaccine

Publish Date June 30, 2022

Researchers assessed the association between the onset of systemic vasculitis following mRNA COVID-19 vaccination.

The Challenges of and New Horizons in Takayasu Arteritis Imaging

Publish Date June 12, 2022

A rheumatologist and radiologist share their perspectives on meeting the challenges of diagnosing and treating Takayasu arteritis.

Prevalence and Predictors of Subclinical Giant Cell Arteritis in Polymyalgia Rheumatica

Publish Date May 31, 2022

Researchers investigated the prevalence and predictors of subclinical giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica.

2018 EULAR Guidelines Validated: Use of Imaging and Pretest Probability in Giant Cell Arteritis Diagnosis

Publish Date May 4, 2022

Researchers assessed the validity of the EULAR recommendations in the use of pretest probability and color duplex ultrasound for the diagnosis of giant cell arteritis.

The American College of Rheumatology and Vasculitis Foundation Release Guidelines for the Management of Kawasaki Disease

Publish Date April 21, 2022

The American College of Rheumatology, in conjunction with the Vasculitis Foundation, developed guidelines for rheumatologists for the management of Kawasaki disease.

Drug-Induced ANCA-Associated Vasculitis: An Update

Publish Date March 4, 2022

In light of new treatments and their adverse reactions, study researchers aimed to update the list of drugs associated with ANCA-associated vasculitis.

ACR/EULAR Release Validated Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis

Publish Date March 1, 2022

The American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) developed and validated revised classification criteria for eosinophilic granulomatosis with polyangiitis.